Skip to main content
Erschienen in: Acta Diabetologica 2/2016

16.06.2015 | Original Article

Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index

verfasst von: Maria J. Redondo, Nicole C. Foster, Ingrid M. Libman, Sanjeev N. Mehta, Joanne M. Hathway, Kathleen E. Bethin, Brandon M. Nathan, Michelle A. Ecker, Avni C. Shah, Stephanie N. DuBose, William V. Tamborlane, Robert P. Hoffman, Jenise C. Wong, David M. Maahs, Roy W. Beck, Linda A. DiMeglio

Erschienen in: Acta Diabetologica | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Aim

The prevalence of cardiovascular risk factors in children with type 1 diabetes and elevated BMI in the USA is poorly defined. We aimed to test the hypothesis that children with type 1 diabetes who are overweight or obese have increased frequencies of hypertension, dyslipidemia, and micro-/macroalbuminuria compared to their healthy weight peers.

Methods

We studied 11,348 children 2 to <18 years of age enrolled in T1D Exchange between September 2010 and August 2012 with type 1 diabetes for ≥1 year and BMI ≥ 5th age-/sex-adjusted percentile (mean age 12 years, 49 % female, 78 % non-Hispanic White). Overweight and obesity were defined based on Centers for Disease Control and Prevention criteria. Diagnoses of hypertension, dyslipidemia, and micro-/macroalbuminuria were obtained from medical records. Logistic and linear regression models were used to assess factors associated with weight status.

Results

Of the 11,348 participants, 22 % were overweight and 14 % obese. Hypertension and dyslipidemia were diagnosed in 1.0 % and 3.8 % of participants, respectively; micro-/macroalbuminuria was diagnosed in 3.8 % of participants with available data (n = 7,401). The odds of either hypertension or dyslipidemia were higher in obese than healthy weight participants [OR 3.5, 99 % confidence interval (CI) 2.0–6.1 and 2.2, 99 % CI 1.6–3.1, respectively]. Obese participants tended to be diagnosed with micro-/macroalbuminuria less often than healthy weight participants (OR 0.6, 99 % CI 0.4–1.0).

Conclusions

Obese children with type 1 diabetes have a higher prevalence of hypertension and dyslipidemia than healthy weight children with type 1 diabetes. The possible association of obesity with lower micro-/macroalbuminuria rates warrants further investigation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Minino AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59(10):1–126 Minino AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59(10):1–126
2.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127(1):e6–e245CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127(1):e6–e245CrossRefPubMed
3.
Zurück zum Zitat Maahs DM, Jalal D, Chonchol M, Johnson RJ, Rewers M, Snell-Bergeon JK (2013) Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care 36(9):2607–2614CrossRefPubMedPubMedCentral Maahs DM, Jalal D, Chonchol M, Johnson RJ, Rewers M, Snell-Bergeon JK (2013) Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care 36(9):2607–2614CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Orchard TJ, Forrest KY, Kuller LH, Becker DJ, Pittsburgh Epidemiology of Diabetes Complications Study (2001) Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24(6):1053–1059CrossRefPubMed Orchard TJ, Forrest KY, Kuller LH, Becker DJ, Pittsburgh Epidemiology of Diabetes Complications Study (2001) Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24(6):1053–1059CrossRefPubMed
5.
Zurück zum Zitat Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55(5):1463–1469CrossRefPubMed Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55(5):1463–1469CrossRefPubMed
6.
Zurück zum Zitat Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29(4):798–804CrossRefPubMed Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29(4):798–804CrossRefPubMed
7.
Zurück zum Zitat Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener JS et al (2001) Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24(7):1233–1239CrossRefPubMed Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener JS et al (2001) Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24(7):1233–1239CrossRefPubMed
8.
Zurück zum Zitat Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ (2001) Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 24(5):823–827CrossRefPubMed Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ (2001) Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 24(5):823–827CrossRefPubMed
9.
Zurück zum Zitat Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR (2004) Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 145(4):452–457CrossRefPubMed Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR (2004) Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 145(4):452–457CrossRefPubMed
10.
Zurück zum Zitat Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765CrossRefPubMed Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765CrossRefPubMed
11.
Zurück zum Zitat Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM et al (2013) Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 36(7):2035–2037CrossRefPubMedPubMedCentral Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM et al (2013) Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 36(7):2035–2037CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Daniels M, DuBose SN, Maahs DM, Beck RW, Fox LA, Gubitosi-Klug R et al (2013) Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care 36(9):2639–2645CrossRefPubMedPubMedCentral Daniels M, DuBose SN, Maahs DM, Beck RW, Fox LA, Gubitosi-Klug R et al (2013) Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care 36(9):2639–2645CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K, Norwegian Study Group for Childhood Diabetes (2008) High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 51(4):554–561CrossRefPubMed Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K, Norwegian Study Group for Childhood Diabetes (2008) High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 51(4):554–561CrossRefPubMed
14.
Zurück zum Zitat Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C (1998) Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 21(6):1004–1007CrossRefPubMed Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C (1998) Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 21(6):1004–1007CrossRefPubMed
15.
Zurück zum Zitat Kaminski BM, Klingensmith GJ, Beck RW, Tamborlane WV, Lee J, Hassan K et al (2013) Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr 162(4):736–740CrossRefPubMed Kaminski BM, Klingensmith GJ, Beck RW, Tamborlane WV, Lee J, Hassan K et al (2013) Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr 162(4):736–740CrossRefPubMed
16.
Zurück zum Zitat Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C et al (2010) Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 11(1):4–11CrossRefPubMed Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C et al (2010) Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 11(1):4–11CrossRefPubMed
17.
Zurück zum Zitat Purnell JQ, Zinman B, Brunzell JD (2013) The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 127(2):180–187CrossRefPubMed Purnell JQ, Zinman B, Brunzell JD (2013) The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 127(2):180–187CrossRefPubMed
18.
Zurück zum Zitat Carmona-Cejudo JM, Hortas ML, Baena-Garcia M, Lana-Linati J, Gonzalez C, Redondo M et al (2012) DB4US: a Decision Support System for Laboratory Information Management. Interact J Med Res 1(2):e16CrossRefPubMedPubMedCentral Carmona-Cejudo JM, Hortas ML, Baena-Garcia M, Lana-Linati J, Gonzalez C, Redondo M et al (2012) DB4US: a Decision Support System for Laboratory Information Management. Interact J Med Res 1(2):e16CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111(15):1970–1977CrossRefPubMed Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111(15):1970–1977CrossRefPubMed
20.
Zurück zum Zitat Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114(24):2710–2738CrossRefPubMed Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114(24):2710–2738CrossRefPubMed
21.
Zurück zum Zitat Redondo MJ, Rodriguez LM, Escalante M, O’Brian Smith E, Balasubramanyam A, Haymond MW (2012) Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 13(7):564–571CrossRefPubMed Redondo MJ, Rodriguez LM, Escalante M, O’Brian Smith E, Balasubramanyam A, Haymond MW (2012) Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 13(7):564–571CrossRefPubMed
22.
Zurück zum Zitat Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ (2003) Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26(10):2871–2875CrossRefPubMed Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ (2003) Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26(10):2871–2875CrossRefPubMed
23.
Zurück zum Zitat Sandhu N, Witmans MB, Lemay JF, Crawford S, Jadavji N, Pacaud D (2008) Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 21(7):631–640CrossRefPubMed Sandhu N, Witmans MB, Lemay JF, Crawford S, Jadavji N, Pacaud D (2008) Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 21(7):631–640CrossRefPubMed
24.
Zurück zum Zitat Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA (2012) The T1D Exchange clinic registry. J Clin Endocrinol Metab 97(12):4383–4389CrossRefPubMed Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA (2012) The T1D Exchange clinic registry. J Clin Endocrinol Metab 97(12):4383–4389CrossRefPubMed
25.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R et al (2002) CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11(246):1–190 Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R et al (2002) CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11(246):1–190
26.
Zurück zum Zitat Barlow SE, Expert C (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(Suppl 4):S164–S192CrossRefPubMed Barlow SE, Expert C (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(Suppl 4):S164–S192CrossRefPubMed
27.
Zurück zum Zitat Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814CrossRefPubMedPubMedCentral Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Anderson J, Pena AS, Sullivan T, Gent R, D’Arcy B, Olds T et al (2013) Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised placebo controlled trial. BMC Pediatr 13:108CrossRefPubMedPubMedCentral Anderson J, Pena AS, Sullivan T, Gent R, D’Arcy B, Olds T et al (2013) Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised placebo controlled trial. BMC Pediatr 13:108CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Liu C, Wu D, Zheng X, Li P, Li L (2015) Efficacy and safety of metformin for patients with type 1 diabetes: a meta-analysis. Diabetes Technol Ther 17:142–148CrossRefPubMed Liu C, Wu D, Zheng X, Li P, Li L (2015) Efficacy and safety of metformin for patients with type 1 diabetes: a meta-analysis. Diabetes Technol Ther 17:142–148CrossRefPubMed
30.
Zurück zum Zitat Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G et al (2007) Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 30(10):2593–2598CrossRefPubMed Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G et al (2007) Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 30(10):2593–2598CrossRefPubMed
31.
Zurück zum Zitat Loghman-Adham M (1998) Evaluating proteinuria in children. Am Fam Physician 58(5):1145–1152, 1158–1159 Loghman-Adham M (1998) Evaluating proteinuria in children. Am Fam Physician 58(5):1145–1152, 1158–1159
32.
Zurück zum Zitat Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR (1982) Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 97(4):516–519CrossRefPubMed Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR (1982) Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 97(4):516–519CrossRefPubMed
33.
Zurück zum Zitat TODAY Study Group (2013) Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 36(6):1772–1774CrossRefPubMedCentral TODAY Study Group (2013) Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 36(6):1772–1774CrossRefPubMedCentral
34.
Zurück zum Zitat Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F (2015) Obesity paradox and risk of mortality events in chronic kidney disease patients: A decade of follow-up in Tehran Lipid and Glucose Study. J Ren Nutr. doi:10.1053/jrn.2014.12.006 PubMed Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F (2015) Obesity paradox and risk of mortality events in chronic kidney disease patients: A decade of follow-up in Tehran Lipid and Glucose Study. J Ren Nutr. doi:10.​1053/​jrn.​2014.​12.​006 PubMed
35.
Zurück zum Zitat TODAY Study Group (2013) Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36:1735–1741CrossRefPubMedCentral TODAY Study Group (2013) Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36:1735–1741CrossRefPubMedCentral
36.
Zurück zum Zitat van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ et al (2010) Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 156(6):923–929CrossRefPubMed van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ et al (2010) Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 156(6):923–929CrossRefPubMed
37.
Zurück zum Zitat Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285–2293CrossRefPubMed Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285–2293CrossRefPubMed
Metadaten
Titel
Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index
verfasst von
Maria J. Redondo
Nicole C. Foster
Ingrid M. Libman
Sanjeev N. Mehta
Joanne M. Hathway
Kathleen E. Bethin
Brandon M. Nathan
Michelle A. Ecker
Avni C. Shah
Stephanie N. DuBose
William V. Tamborlane
Robert P. Hoffman
Jenise C. Wong
David M. Maahs
Roy W. Beck
Linda A. DiMeglio
Publikationsdatum
16.06.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2016
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0785-1

Weitere Artikel der Ausgabe 2/2016

Acta Diabetologica 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.